STANKOVICH THOMAS

Related Filers (5)

Ownership (39)

4
Wednesday, 11/8/2023
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2023
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/7/2023
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/20/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/10/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/6/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/12/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/11/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/6/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/12/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/8/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/28/2022
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/9/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/18/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/16/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/12/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/31/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/24/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
ReShape Lifesciences Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/17/2021
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/17/2020
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/20/2020
ReShape Lifesciences Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 11/8/2019
ReShape Lifesciences Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/27/2010
RESPONSE GENETICS INC: Statement of changes in beneficial ownership of securities
4
Monday, 12/14/2009
RESPONSE GENETICS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/6/2007
RESPONSE GENETICS INC: Statement of changes in beneficial ownership of securities
3
Monday, 6/4/2007
RESPONSE GENETICS INC: Initial statement of beneficial ownership of securities
4
Tuesday, 11/14/2006
Cobalis Corp: Statement of changes in beneficial ownership of securities
4
Thursday, 11/2/2006
Cobalis Corp: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/11/2006
Cobalis Corp: Statement of changes in beneficial ownership of securities
3
Monday, 12/12/2005
Cobalis Corp: Initial statement of beneficial ownership of securities
5
Thursday, 1/30/2003
RIBAPHARM INC: Annual statement of changes in beneficial ownership of securities
4
Friday, 12/6/2002
RIBAPHARM INC: Statement of changes in beneficial ownership of securities
Show More